Quest and UCSF Pilot Novel Approach to Dementia Screening and Care with Top ACO in NY

Innovation

Primary PartnerCare will pilot a “clinical pathway” designed by Quest Diagnostics and the UCSF Memory and Aging Center.

22q11.2 Deletion Syndrome: Awareness Can Make a Difference

Insights

Prenatal screening for the 22q11.2 deletion is now available by cell-free DNA screening, also known as noninvasive prenatal screening.

Quest Recognized on Disability Equality Index

Our People

We are proud that Quest Diagnostics has been listed on the Disability Equality Index® (DEI), a joint initiative of the American Association of People with Disabilities (AAPD) and the US Business Leadership Network (USBLN), recognizing companies for prioritizing the inclusion of people with disabilities.

What is the APOE gene and how is it related to Alzheimer’s Disease?

Insights

There is currently no proven way to prevent or cure Alzheimer disease. Is there a role for genetic testing to predict risk?

Does Every Patient with a Tick Bite Need a Test for Lyme Disease?

Insights

Important considerations for determining if a Lyme Disease test is necessary include tick identification, geography, symptoms and signs, and duration of tick attachment.

Tick-borne Illnesses: The Risks of a Missed Diagnosis

Insights

Once thought to be required for the diagnosis, it is now clear that up to 30% of patients with Lyme disease never develop a rash.

Older Patients with Chronic Conditions Can Benefit from Extra Care

Better Health

Chronic Care Management (CCM) services are one of the ways in which Quest is moving beyond medical office walls to aid providers in assessing individuals and populations and closing gaps in care.

Cystic Fibrosis – Pathway to a Cure

Better Health

Did you know that although it can occur in any ethnic group, cystic fibrosis (CF) is the most common and severe inherited disease in Caucasians?